Adamantane-platinum conjugate hosted in β-cyclodextrin: Enhancing transport and cytotoxicity by noncovalent modification

Deepali Prashar, Yi Shi, Debjyoti Bandyopadhyay, James C. Dabrowiak, Yan Yeung Luk

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This work reports the synthesis of a complex of a carboplatin analog having tethered adamantane that is encapsulated in the hydrophobic cavity of β-cyclodextrin (βCD) and its cytotoxic activity towards human neuroblastoma cells (SK-N-SH). We found that this inclusion complex of βCD adamantane carboplatin analog exhibited higher cytotoxicity towards SK-N-SH cells than carboplatin itself, and the inclusion complex exhibited a higher binding to plasmid pBR322 deoxyribonucleic acid (DNA) than carboplatin. Confocal fluorescence images of SK-N-SH cells treated with βCD having an attached fluorescein isothiocyanate (FITC)-tag exhibited fluorescence in the vicinity of the nuclei of the neuroblastoma cells. Direct measurements of the platinum content in SK-N-SH cells using inductively coupled plasma mass spectrometry (ICP-MS) indicated that the uptake rate of carboplatin was about 4 times higher than βCD adamantane carboplatin analog inclusion complex. When compared to carboplatin, we believe that the higher cytotoxicity of inclusion complex towards SK-N-SH cells is due to its higher DNA binding ability as compared to carboplatin, and more efficient delivery to the nucleus of the cell. This work suggests that the advantage of deliberate noncovalent modification with βCD through host-guest chemistry may also be broadly applicable to other anticancer agents as well.

Original languageEnglish (US)
Pages (from-to)7421-7425
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number24
DOIs
StatePublished - Dec 15 2011

Fingerprint

Adamantane
Carboplatin
Cyclodextrins
Cytotoxicity
Platinum
Cell Nucleus
Neuroblastoma
Fluorescence
Inductively coupled plasma mass spectrometry
DNA
Fluorescein
Human Activities
Antineoplastic Agents
Mass Spectrometry
Plasmids

Keywords

  • Anticancer agents
  • Cyclodextrins
  • DNA
  • Host-guest chemistry
  • Noncovalent modification
  • Solvation

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Adamantane-platinum conjugate hosted in β-cyclodextrin : Enhancing transport and cytotoxicity by noncovalent modification. / Prashar, Deepali; Shi, Yi; Bandyopadhyay, Debjyoti; Dabrowiak, James C.; Luk, Yan Yeung.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 21, No. 24, 15.12.2011, p. 7421-7425.

Research output: Contribution to journalArticle

Prashar, Deepali ; Shi, Yi ; Bandyopadhyay, Debjyoti ; Dabrowiak, James C. ; Luk, Yan Yeung. / Adamantane-platinum conjugate hosted in β-cyclodextrin : Enhancing transport and cytotoxicity by noncovalent modification. In: Bioorganic and Medicinal Chemistry Letters. 2011 ; Vol. 21, No. 24. pp. 7421-7425.
@article{d9a0c757fa7345ef94dae04f6e71ccdf,
title = "Adamantane-platinum conjugate hosted in β-cyclodextrin: Enhancing transport and cytotoxicity by noncovalent modification",
abstract = "This work reports the synthesis of a complex of a carboplatin analog having tethered adamantane that is encapsulated in the hydrophobic cavity of β-cyclodextrin (βCD) and its cytotoxic activity towards human neuroblastoma cells (SK-N-SH). We found that this inclusion complex of βCD adamantane carboplatin analog exhibited higher cytotoxicity towards SK-N-SH cells than carboplatin itself, and the inclusion complex exhibited a higher binding to plasmid pBR322 deoxyribonucleic acid (DNA) than carboplatin. Confocal fluorescence images of SK-N-SH cells treated with βCD having an attached fluorescein isothiocyanate (FITC)-tag exhibited fluorescence in the vicinity of the nuclei of the neuroblastoma cells. Direct measurements of the platinum content in SK-N-SH cells using inductively coupled plasma mass spectrometry (ICP-MS) indicated that the uptake rate of carboplatin was about 4 times higher than βCD adamantane carboplatin analog inclusion complex. When compared to carboplatin, we believe that the higher cytotoxicity of inclusion complex towards SK-N-SH cells is due to its higher DNA binding ability as compared to carboplatin, and more efficient delivery to the nucleus of the cell. This work suggests that the advantage of deliberate noncovalent modification with βCD through host-guest chemistry may also be broadly applicable to other anticancer agents as well.",
keywords = "Anticancer agents, Cyclodextrins, DNA, Host-guest chemistry, Noncovalent modification, Solvation",
author = "Deepali Prashar and Yi Shi and Debjyoti Bandyopadhyay and Dabrowiak, {James C.} and Luk, {Yan Yeung}",
year = "2011",
month = "12",
day = "15",
doi = "10.1016/j.bmcl.2011.10.006",
language = "English (US)",
volume = "21",
pages = "7421--7425",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier",
number = "24",

}

TY - JOUR

T1 - Adamantane-platinum conjugate hosted in β-cyclodextrin

T2 - Enhancing transport and cytotoxicity by noncovalent modification

AU - Prashar, Deepali

AU - Shi, Yi

AU - Bandyopadhyay, Debjyoti

AU - Dabrowiak, James C.

AU - Luk, Yan Yeung

PY - 2011/12/15

Y1 - 2011/12/15

N2 - This work reports the synthesis of a complex of a carboplatin analog having tethered adamantane that is encapsulated in the hydrophobic cavity of β-cyclodextrin (βCD) and its cytotoxic activity towards human neuroblastoma cells (SK-N-SH). We found that this inclusion complex of βCD adamantane carboplatin analog exhibited higher cytotoxicity towards SK-N-SH cells than carboplatin itself, and the inclusion complex exhibited a higher binding to plasmid pBR322 deoxyribonucleic acid (DNA) than carboplatin. Confocal fluorescence images of SK-N-SH cells treated with βCD having an attached fluorescein isothiocyanate (FITC)-tag exhibited fluorescence in the vicinity of the nuclei of the neuroblastoma cells. Direct measurements of the platinum content in SK-N-SH cells using inductively coupled plasma mass spectrometry (ICP-MS) indicated that the uptake rate of carboplatin was about 4 times higher than βCD adamantane carboplatin analog inclusion complex. When compared to carboplatin, we believe that the higher cytotoxicity of inclusion complex towards SK-N-SH cells is due to its higher DNA binding ability as compared to carboplatin, and more efficient delivery to the nucleus of the cell. This work suggests that the advantage of deliberate noncovalent modification with βCD through host-guest chemistry may also be broadly applicable to other anticancer agents as well.

AB - This work reports the synthesis of a complex of a carboplatin analog having tethered adamantane that is encapsulated in the hydrophobic cavity of β-cyclodextrin (βCD) and its cytotoxic activity towards human neuroblastoma cells (SK-N-SH). We found that this inclusion complex of βCD adamantane carboplatin analog exhibited higher cytotoxicity towards SK-N-SH cells than carboplatin itself, and the inclusion complex exhibited a higher binding to plasmid pBR322 deoxyribonucleic acid (DNA) than carboplatin. Confocal fluorescence images of SK-N-SH cells treated with βCD having an attached fluorescein isothiocyanate (FITC)-tag exhibited fluorescence in the vicinity of the nuclei of the neuroblastoma cells. Direct measurements of the platinum content in SK-N-SH cells using inductively coupled plasma mass spectrometry (ICP-MS) indicated that the uptake rate of carboplatin was about 4 times higher than βCD adamantane carboplatin analog inclusion complex. When compared to carboplatin, we believe that the higher cytotoxicity of inclusion complex towards SK-N-SH cells is due to its higher DNA binding ability as compared to carboplatin, and more efficient delivery to the nucleus of the cell. This work suggests that the advantage of deliberate noncovalent modification with βCD through host-guest chemistry may also be broadly applicable to other anticancer agents as well.

KW - Anticancer agents

KW - Cyclodextrins

KW - DNA

KW - Host-guest chemistry

KW - Noncovalent modification

KW - Solvation

UR - http://www.scopus.com/inward/record.url?scp=81255154461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255154461&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2011.10.006

DO - 10.1016/j.bmcl.2011.10.006

M3 - Article

C2 - 22050886

AN - SCOPUS:81255154461

VL - 21

SP - 7421

EP - 7425

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 24

ER -